NPR’s Ailsa Chang talks with Eli Lilly CEO David Ricks about the company’s move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.
Eli Lilly CEO David Ricks comments on why it’s cutting insulin prices now
